At a glance
ClinicalIndex Comparison RecordN/ACompleted· 430 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Molecular Signature of Karen and Burmese Pregnant Women on the Thailand-Myanmar Border
In Brief
An observational study for Pregnancy. Completed, enrolled 430 participants across 1 site.
Detailed Summary
The primary goal of the study is to identify biomarkers from the molecular signature predictive of pre-term birth. This will be achieved through high frequency sampling and profiling throughout pregnancy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
CountriesThailand
CollaboratorsSidra Medicine
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartSep 2016
Primary CompletionJan 2023
TodayJul 2026
First PostedJun 13, 2016
Enrollment StartSep 12, 2016
Primary CompletionJan 30, 2023
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 10.1 years ago